CLABSI Prevention Bundle — Central Line-Associated Bloodstream Infection

Central line-associated bloodstream infection (CLABSI) prevention bundle for Georgian ICUs and high-dependency units: insertion bundle, maintenance bundle, daily review checklist and surveillance definitions.

Regulations › IPC Resources

Type
IPC Prevention Bundle
Scope
ICUs, HDUs, oncology and all units placing or maintaining central venous catheters
Source
WHO IPC core components; CDC/NHSN CLABSI definitions; IHI Central Line Bundle
Publisher
PHIG Georgia
Updated
2025

Central line-associated bloodstream infection (CLABSI) is one of the most serious and costly healthcare-associated infections — with mortality rates of 12–25% and average attributable costs exceeding $45,000 per episode.[1][2] Evidence shows that implementing a structured 5-element insertion bundle reduces CLABSI rates by up to 66%.[1][3] This bundle is the standard of care for all Georgian facilities managing central venous catheters.

66%reduction in catheter-related bloodstream infections after a bundle-based intervention in 103 ICUs (Keystone ICU project)Source: Pronovost et al., NEJM 2006
5elements in the insertion bundle — all must be doneSource: CLABSI bundle
Dailyline necessity review — remove the line when no longer neededSource: CLABSI bundle

Insertion bundle — all 5 elements are mandatory, every insertion

#Bundle elementStandard
1Hand hygieneSurgical hand scrub or ABHR rub before donning sterile gloves; performed immediately before the procedure
2Maximal barrier precautionsOperator: sterile gloves + sterile gown + surgical mask + cap; Patient: large sterile drape covering entire body except insertion site
3Chlorhexidine skin antisepsis2% chlorhexidine gluconate in 70% isopropyl alcohol; apply with back-and-forth scrubbing for 30 seconds; allow to air dry completely (≥30 seconds) before insertion. Alternative: 10% povidone-iodine if chlorhexidine contraindicated (allergy, age <2 months)
4Optimal catheter site selectionSubclavian vein preferred for non-tunnelled lines (lowest CLABSI risk)[2]; femoral vein avoided unless no alternative (highest infection and DVT risk); internal jugular acceptable; document site selection rationale
5Daily review of line necessity — remove promptlyWritten checklist reviewed by physician daily: does this patient still need this central line? Remove as soon as no longer clinically indicated. Lines not reviewed daily are a protocol violation.

Maintenance bundle — daily care of every central line

ElementStandardFrequency
Dressing managementTransparent semi-permeable dressing (TSM) changed every 7 days and when wet, loose or soiled; gauze dressing changed every 2 days; sterile technique for all dressing changes; chlorhexidine-impregnated patch at exit site recommended for high-risk patientsPer schedule or when indicated
Needleless connector careDisinfect connector with 70% alcohol or chlorhexidine swab before each access; scrub for minimum 15 seconds and allow to dry; change connector every 96 hours or when removed for any reasonBefore each access
Administration set changesStandard IV sets: every 96 hours; lipid-containing solutions: every 24 hours; blood and blood products: within 4 hours of initiating each unit; propofol: per manufacturer guidancePer schedule
Exit site inspectionInspect at every dressing change for erythema, induration, purulence, tenderness; document findings; if infection suspected — notify physician immediately, consider line removalEvery dressing change + daily visual check
Line necessity reviewDocument daily: clinical indication still present? Potential to convert to peripheral or oral therapy? Goal: line days minimisedDaily

CLABSI surveillance case definition (NHSN/WHO)

Key point

CLABSI = laboratory-confirmed bloodstream infection (LCBI) in a patient who had a central line in place for >2 calendar days on the date of the event AND the central line was in place on the date of the event or the day before, AND the BSI is not secondary to an infection at another body site. Laboratory criteria: recognised pathogen cultured from ≥1 blood culture[6]; OR common commensal (coagulase-negative Staph, Bacillus spp., Corynebacterium spp., Propionibacterium, viridans streptococci, Aerococcus, Micrococcus) from ≥2 blood cultures drawn on separate occasions AND at least one of: fever >38°C, chills, or hypotension. CLABSI rate = CLABSI events ÷ central line-days × 1,000.

In plain language

The CLABSI bundle is a small set of evidence-based steps that, done together every time, prevent bloodstream infections from central venous catheters: at insertion and throughout maintenance.

Why it matters

4.3Mpatients a year in EU/EEA hospitals acquire at least one healthcare-associated infectionSource: ECDC PPS 2022–2023
11.9%of healthcare-associated infections in EU/EEA hospitals were bloodstream infectionsSource: ECDC PPS 2022–2023, via CIDRAP
Types of healthcare-associated infection, EU/EEA acute care hospitals 2022–2023 (% of all HAIs)
Respiratory tract29.3%
Urinary tract19.2%
Surgical site16.1%
Bloodstream11.9%
Gastrointestinal9.5%
Source: ECDC point prevalence survey 2022–2023, via CIDRAP

Key actions checklist

  • Hand hygiene before insertion and every access
  • Maximal sterile barrier precautions at insertion
  • Chlorhexidine-based skin antisepsis
  • Optimal site selection, avoiding the femoral vein in adults where possible
  • Daily review of line necessity and prompt removal

International guidance

Questions and answers

Why a bundle rather than single measures?

The effect comes from applying all elements together, reliably, and auditing compliance.

How is success measured?

CLABSI rate per 1,000 catheter-days and bundle compliance.

Georgian original source / ქართული წყარო

Georgian IPC National Guideline and NCDC HAI Surveillance — NCDC Georgia

Open Georgian source →Additional reference →

NCDC Georgia HAI surveillance protocols (Georgian). CDC NHSN CLABSI surveillance definition (English) — the international standard used in Georgia.

References

  1. [1] Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732. doi:10.1056/NEJMoa061115
  2. [2] O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–e193. doi:10.1093/cid/cir257
  3. [3] Institute for Healthcare Improvement (IHI). How-to Guide: Prevent Central Line-Associated Bloodstream Infections. IHI. 2012;—:—. Available at: https://www.ihi.org/resources/Pages/Tools/HowtoGuidePreventCentralLineAssociatedBloodstreamInfection.aspx
  4. [4] WHO. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. World Health Organization. 2016;—:—. Available at: https://www.who.int/publications/i/item/9789241549929
  5. [5] Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update. Clin Infect Dis. 2009;49(1):1–45. doi:10.1086/599376
  6. [6] CDC/NHSN. NHSN Patient Safety Component Manual: Central Line-Associated Bloodstream Infection (CLABSI) Event. Centers for Disease Control and Prevention. 2024;—:—. Available at: https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
PHIG Published by the Public Health Institute of Georgia (PHIG) · Regulations Hub · Contact PHIG